Tolerability of bevacizumab in elderly patients with ovarian cancer: an experience from the Department of Gynecologic Oncology in the University Hospital Centre Zagreb

Tolerability of bevacizumab in elderly patients with ovarian cancer: an experience from the Department of Gynecologic Oncology in the University Hospital Centre Zagreb

Introduction: Bevacizumab is a recombinant humanized anti-VEGF monoclonal antibody. It is an effective treatment for epithelial ovarian cancer, both in primary and recurrent disease. The incidence of ovarian cancer increases with advancing age. Despite the high prevalence of the ovarian cancer in el...

Full description

Bibliographic Details
Main Authors: Kristina Katić, Višnja Matković, Joško Lešin, Goran Vujić, Ante Ćorušić
Format: Article
Language:English
Published: University Hospital for Tumors 2021-01-01
Series:Libri Oncologici
Subjects:
ovary cancer
bevacizumab
therapy
elderly patients
Online Access:https://hrcak.srce.hr/file/374616

Similar Items

Similar Items